These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 30156713)
1. Stakeholders analysis of merging social health insurance funds in Iran: what kind of interests they may gain or lose? Bazyar M; Rashidian A; Sakha MA; Doshmangir L; Rahimi N; Ranjbar M; Sagha Abolfazl SF; Tabatabaei Lotfi SM; Olyaeemanesh A Int J Health Plann Manage; 2019 Jan; 34(1):157-176. PubMed ID: 30156713 [TBL] [Abstract][Full Text] [Related]
2. Combining health insurance funds in a fragmented context: what kind of challenges should be considered? Bazyar M; Rashidian A; Alipouri Sakha M; Vaez Mahdavi MR; Doshmangir L BMC Health Serv Res; 2020 Jan; 20(1):26. PubMed ID: 31915003 [TBL] [Abstract][Full Text] [Related]
3. What are the potential advantages and disadvantages of merging health insurance funds? A qualitative policy analysis from Iran. Bazyar M; Yazdi-Feyzabadi V; Rahimi N; Rashidian A BMC Public Health; 2020 Aug; 20(1):1315. PubMed ID: 32867732 [TBL] [Abstract][Full Text] [Related]
4. Policy Options to Reduce Fragmentation in the Pooling of Health Insurance Funds in Iran. Bazyar M; Rashidian A; Kane S; Vaez Mahdavi MR; Akbari Sari A; Doshmangir L Int J Health Policy Manag; 2016 Feb; 5(4):253-8. PubMed ID: 27239868 [TBL] [Abstract][Full Text] [Related]
5. The experiences of merging health insurance funds in South Korea, Turkey, Thailand, and Indonesia: a cross-country comparative study. Bazyar M; Yazdi-Feyzabadi V; Rashidian A; Behzadi A Int J Equity Health; 2021 Feb; 20(1):66. PubMed ID: 33637090 [TBL] [Abstract][Full Text] [Related]
6. Understanding conflicts of interest in rational drug prescription in a developing country: A stakeholder analysis, healthcare guidelines and ethical public health issues. Moradi F; Bazyar M; Soroush A; Seyedin H; Soleymani F; Etemadi M; Ezadi S; Salimi M; Behzadifar M; Martini M; Hussain R J Prev Med Hyg; 2023 Sep; 64(3):E358-E366. PubMed ID: 38126000 [TBL] [Abstract][Full Text] [Related]
7. Social insurance for dental care in Iran: a developing scheme for a developing country. Jadidfard MP; Yazdani S; Khoshnevisan MH Oral Health Dent Manag; 2012 Dec; 11(4):189-98. PubMed ID: 23208596 [TBL] [Abstract][Full Text] [Related]
8. Fail to prepare and you can prepare to fail: the experience of financing path changes in teaching hospitals in Iran. Doshmangir L; Rashidian A; Jafari M; Ravaghi H; Takian A BMC Health Serv Res; 2016 Apr; 16():138. PubMed ID: 27102262 [TBL] [Abstract][Full Text] [Related]
9. Diffusion of advanced medical imaging technology, CT, and MRI scanners, in Iran: A qualitative study of determinants. Abedini Z; Sari AA; Foroushani AR; Jaafaripooyan E Int J Health Plann Manage; 2019 Jan; 34(1):e397-e410. PubMed ID: 30289584 [TBL] [Abstract][Full Text] [Related]
10. Challenges of implementation: Strategic purchasing in Iran Health Insurance Organization. Kalantari AR; Jafari Sirizi M; Mehrolhassani MH; Dehnavieh R Int J Health Plann Manage; 2019 Jan; 34(1):e875-e884. PubMed ID: 30408235 [TBL] [Abstract][Full Text] [Related]
11. Financing of physical rehabilitation services in Iran: a stakeholder and social network analysis. Shahabi S; Ahmadi Teymourlouy A; Shabaninejad H; Kamali M; Lankarani KB BMC Health Serv Res; 2020 Jul; 20(1):599. PubMed ID: 32611339 [TBL] [Abstract][Full Text] [Related]
12. Universal Health Insurance Coverage in Vietnam: A Stakeholder Analysis From Policy Proposal (1989) to Implementation (2014). Hoang CK; Hill P; Nguyen HT J Public Health Manag Pract; 2018; 24 Suppl 2():S52-S59. PubMed ID: 29369257 [TBL] [Abstract][Full Text] [Related]
13. Social movements and health insurance: a critical evaluation of voluntary, non-profit insurance schemes with case studies from Ghana and Cameroon. Atim C Soc Sci Med; 1999 Apr; 48(7):881-96. PubMed ID: 10192556 [TBL] [Abstract][Full Text] [Related]
14. Power structure among the actors of financial support to the poor to access health services: Social network analysis approach. Etemadi M; Gorji HA; Kangarani HM; Ashtarian K Soc Sci Med; 2017 Dec; 195():1-11. PubMed ID: 29096148 [TBL] [Abstract][Full Text] [Related]
15. Eliminating Healthcare-Associated Infections in Iran: A Qualitative Study to Explore Stakeholders' Views. Esfandiari A; Salari H; Rashidian A; Masoumi Asl H; Rahimi Foroushani A; Akbari Sari A Int J Health Policy Manag; 2018 Jan; 7(1):27-34. PubMed ID: 29325400 [TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis. Olyaaeemanesh A; Jaafaripooyan E; Abdollahiasl A; Davari M; Mousavi SM; Delpasand M Health Res Policy Syst; 2021 Dec; 19(1):150. PubMed ID: 34949207 [TBL] [Abstract][Full Text] [Related]
17. Health Sector Evolution Plan in Iran; Equity and Sustainability Concerns. Moradi-Lakeh M; Vosoogh-Moghaddam A Int J Health Policy Manag; 2015 Aug; 4(10):637-40. PubMed ID: 26673172 [TBL] [Abstract][Full Text] [Related]
18. Iran's health insurance ecosystem: challenges and strategies. Rahimisadegh R; Noori Hekmat S; Mehrolhassani MH; Jafari Sirizi M BMC Public Health; 2024 Sep; 24(1):2470. PubMed ID: 39256666 [TBL] [Abstract][Full Text] [Related]
19. The experience of implementing the board of trustees' policy in teaching hospitals in Iran: an example of health system decentralization. Doshmangir L; Rashidian A; Ravaghi H; Takian A; Jafari M Int J Health Policy Manag; 2015 Apr; 4(4):207-16. PubMed ID: 25844379 [TBL] [Abstract][Full Text] [Related]
20. Integrated early childhood development policy in Iran: a stakeholder analysis. Atashbahar O; Sari AA; Takian A; Olyaeemanesh A; Mohamadi E; Barakati SH BMC Health Serv Res; 2021 Sep; 21(1):971. PubMed ID: 34526031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]